Triage TOX Evaluation Shows Why Benzodiazepine Screening Agreement Needs a Comparator Definition

A rapid urine screen can agree well overall while still producing drug-class discrepancies requiring investigation.

What the supplied source reports

The laboratory study compared an eleven-target immunoassay with a mass-spectrometric method in 105 urine samples. Benzodiazepine results included discordances. Near-cutoff precision testing also demonstrated a transition region where repeated results were not uniformly positive or negative. Reported benzodiazepine positive and negative agreement were not identical.

Limits of the evidence

The study did not quantify every detected drug, and comparator coverage and cutoffs constrain interpretation. A comparator-negative result is not proof that no cross-reacting benzodiazepine or metabolite exists. Agreement statistics are not automatically sensitivity and specificity against a perfect reference standard.

Implications for forensic interpretation

For testimony, identify the calibrator, cross-reactivity, cutoff and confirmatory analyte list. A positive class screen does not identify which benzodiazepine was present or establish impairment. A negative result near a cutoff is also different from demonstrated absence of exposure; the analytical question must match the conclusion.

Source and related reading

Source reviewed: Evaluation of the Triage TOX Drug Screen Assay for Detection of 11 Drugs of Abuse and Therapeutic Dr (PMC5587826). Forensic applications above are interpretive analysis of the supplied publication.